89179-61-3 Usage
Uses
Used in Pharmaceutical Industry:
Pyrazinol, 3-amino-5-methyl(7CI) is used as a key intermediate in the synthesis of various drugs and pharmaceuticals. Its unique structure allows for the development of new therapeutic agents with potential applications in treating a range of medical conditions.
Used in Organic Synthesis:
Pyrazinol, 3-amino-5-methyl(7CI) serves as a building block in organic synthesis, enabling the creation of a wide range of complex molecules. Its versatile chemical properties make it an essential component in the development of novel compounds with diverse applications in the chemical industry.
Used in Therapeutic Research:
Pyrazinol, 3-amino-5-methyl(7CI) has been studied for its potential therapeutic effects in the treatment of certain medical conditions. Its unique structure and properties make it a promising candidate for further research and development in the field of medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 89179-61-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,1,7 and 9 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 89179-61:
(7*8)+(6*9)+(5*1)+(4*7)+(3*9)+(2*6)+(1*1)=183
183 % 10 = 3
So 89179-61-3 is a valid CAS Registry Number.
89179-61-3Relevant academic research and scientific papers
DIHYDROQUINAZOLIN-2-ONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS USEFUL IN THE TREATMENT OF HIV
-
Page/Page column 62, (2022/03/22)
The present disclosure is directed to tetrahydroquinazoline derivatives of Formula I and their use for selectively killing HIV infected GAG-POL expressing cells without concomitant cytotoxicity to HIV na?ve cells, and for the treatment or prophylaxis of infection by HIV, or for the treatment, prophylaxis or delay in the onset or progression of AIDS or AIDS Related Complex (ARC).
IMIDAZOPYRAZINE COMPOUNDS
-
Page/Page column 69-70, (2009/04/25)
Novel imidazopyrazine compounds are disclosed that have a formula represented by the following: Formula (I). The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a viral infection, in particular a HCV, HRV, Sb and/or CVB in a patient in need thereof.
